Cellular & Molecular Biology of Cancer

Date: February 25 - March 1, 2002
Location: Wolfson Conference Centre, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, England

Symposium Web Page: www.med.ic.ac.uk/divisions/cc/wolfson.asp

Objectives: This is the 7th year of an intensive 5-day course presented by international distinguished experts.The format consists of 30 overviews in the experimental,clinical and technical advances in neoplasia and tissue regeneration. The course has a broad appeal to graduate students,post-docs,clinical fellows,and clinicians (both junior and senior)as well as physicians,surgeons,oncologists,clinical and biomedical scientists considering or presently undertaking MSc,MD or PhD degrees.The course content is also relevant to candidates for FRCS,MRCP and MRCPath examinations or those wanting to update their specific areas of interest.

Topics: The Cellular and Molecular Biology of Cancer

Agenda: The broad themes of the selected reviews are:

  • Day 1:Molecular mechanisms of cancer invasion and metastasis
  • Day 2:Hormones,cytokines and growth factors
  • Day 3:Cell cycle and programmed cell death control and regulation
  • Day 4:Methodologies in Experimental and Clinical Laboratory Research
  • Day 5:High throughput technologies and therapeutic advances

Fees: By January 23, 2002 £395.00, full course (including catering); £110.00 per day (including catering). After January 23, 2002, £450.00 full course (including catering); £125.00 per day (including catering).


Wolfson Conference Centre
Imperial College School of Medicine
Hammersmith Hospital
Du Cane Road
London W12 ONN

Tel: +44 (0)20 8383 3117/3227/3245
Fax: +44 (0)20 8383 2428
Email: wcc@ic.ac.uk

Related News

Probable/Possible Carcinogenic HPV Types Are Biologically Active

Nov 18, 2014

Frequencies of five markers not significantly different in pHR-HPV and other high-risk HPV

2002 to 2008 Saw Increase in Partial Nephrectomy Use

Feb 20, 2012

For patients with renal masses, use of partial nephrectomy increased from 15.3 to 24.7 percent

Participants had regular mammography; changes parallel drop in hormone therapy use after 2002

Nov 12, 2010

Participants had regular mammography; changes parallel drop in hormone therapy use after 2002